MedTrace Logo

Heat thErapy And mobiLity in COVID-19 Survivors

NCT06928116 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 99

Last updated 2025-10-23

No results posted yet for this study

Summary

Post-acute sequelae of SARS-CoV-2 infection (PASC) is becoming a major risk factor for chronic diseases, with older adults and those with underlying health conditions at risk of developing persistent mobility limitations and disabilities. Although exercise intervention is a common strategy to restore functional capacity, it may not be feasible or enticing to many people with PASC. This clinical trial seeks to establish the tolerability and efficacy of at home lower-body heat therapy for improving functional capacity along with metabolic and vascular health in late-middle aged and older adults with PASC, also known as "long COVID".

Conditions

Interventions

BEHAVIORAL

Heat therapy

At home lower body heat therapy

BEHAVIORAL

Sham Control

Sham Thermoneutral

BEHAVIORAL

Walking

Walking intervention

Sponsors & Collaborators

  • National Institute on Aging (NIA)

    collaborator NIH

  • University of Nebraska

    lead OTHER

Principal Investigators

  • Gwenael Layec, PhD · University of Nebraska

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-17
Primary Completion
2028-08-31
Completion
2029-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06928116 on ClinicalTrials.gov